These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1882717)

  • 41. Meningioma.
    Kujas M
    Curr Opin Neurol; 1993 Dec; 6(6):882-7. PubMed ID: 8293162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Estrogen and progestin receptors in meningiomas: a study in 22 cases (author's transl)].
    Poisson M; Magdelenat H; Foncin JF; Bleibel JM; Philippon J; Pertuiset B; Buge A
    Rev Neurol (Paris); 1980; 136(3):193-203. PubMed ID: 7414146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Behavior of estrogen and progesterone receptors in intracranial meningioma].
    Oddi G; Rebeck L; Bruni P
    Pathologica; 1989; 81(1075):515-22. PubMed ID: 2641153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormone receptors in initially excised versus recurrent intracranial meningiomas.
    Rubinstein AB; Loven D; Geier A; Reichenthal E; Gadoth N
    J Neurosurg; 1994 Aug; 81(2):184-7. PubMed ID: 8027799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation of expression of progesterone receptors with histopathological type and grade of malignancy of cerebral neoplasms].
    Och W; Mariak Z; Kopeć J; Smółka M; Koziorowski M
    Neurol Neurochir Pol; 2001; 35 Suppl 5():110-8. PubMed ID: 11935670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem-cell assay.
    Grunberg SM; Daniels AM; Muensch H; Daniels JR; Bernstein L; Kortes V; Weiss MH
    J Neurosurg; 1987 Mar; 66(3):405-8. PubMed ID: 3819835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progesterone receptor expression in meningiomas.
    Carroll RS; Glowacka D; Dashner K; Black PM
    Cancer Res; 1993 Mar; 53(6):1312-6. PubMed ID: 8443810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoreactive estrogen receptor protein in meningiomas: comparison with the androgen receptor and progesterone receptor binding activity.
    Lesch KP; Engl HG; Schott W; Gross S
    Zentralbl Neurochir; 1987; 48(2):124-34. PubMed ID: 3314266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor.
    Blankenstein MA; Berns PM; Blaauw G; Mulder E; Thijssen JH
    Cancer Res; 1986 Aug; 46(8 Suppl):4268s-4270s. PubMed ID: 3731090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium.
    Geisinger KR; Marshall RB; Kute TE; Homesley HD
    Cancer; 1986 Oct; 58(7):1506-17. PubMed ID: 3742469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?
    Fewings PE; Battersby RD; Timperley WR
    J Neurosurg; 2000 Mar; 92(3):401-5. PubMed ID: 10701525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
    Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
    Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex hormone binding and peritumoural oedema in meningiomas: is there a correlation?
    Meixensberger J; Caffier H; Naumann M; Hofmann E
    Acta Neurochir (Wien); 1992; 115(3-4):98-102. PubMed ID: 1605091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
    Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
    Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].
    Fornelli A; Bacci A; Collina G; Eusebi V
    Pathologica; 1995 Oct; 87(5):506-12. PubMed ID: 8868176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases.
    Perry A; Cai DX; Scheithauer BW; Swanson PE; Lohse CM; Newsham IF; Weaver A; Gutmann DH
    J Neuropathol Exp Neurol; 2000 Oct; 59(10):872-9. PubMed ID: 11079777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays.
    Halper J; Colvard DS; Scheithauer BW; Jiang NS; Press MF; Graham ML; Riehl E; Laws ER; Spelsberg TC
    Neurosurgery; 1989 Oct; 25(4):546-52; discussion 552-3. PubMed ID: 2477767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrameningioma metastasis as first clinical manifestation of occult primary breast carcinoma.
    Caroli E; Salvati M; Giangaspero F; Ferrante L; Santoro A
    Neurosurg Rev; 2006 Jan; 29(1):49-54. PubMed ID: 16133455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.